36 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
29 Sep 23
InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
5:18pm
optimized and scaled up manufacturing processes to meet increasing demand, secured more sources of raw materials as well as secured additional downstream
8-K
EX-99.1
kkmkocmxg620bpf
20 Jul 23
Regulation FD Disclosure
2:18pm
424B5
8lhwrp0e99 11
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
z67gs57cxs
25 Apr 22
Prospectus supplement
5:02pm
424B3
9y4wz0h99 6bece6l
7 Apr 22
Prospectus supplement
4:46pm
S-3
89l2ed6xustn1tz4vsqn
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
dd6h5n9e
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
00rbtpnopyuu1 vc1
24 Sep 21
Annual report
7:31am